Our Experts
Back to all Experts
Claudine Jurkovitz, M.D., MPH
Director of Clinical Research, Institute for Research on Equity and Community Health (iREACH)
Expertise & Research Interests
- Health Services Research
- Chronic Disease Epidemiology
- Nephrology
- Electronic Health Records
Education
- MPH, Emory University, Atlanta, GA, USA:
- M.D., Medical School, Grenoble, France
Claudine Jurkovitz, M.D., MPH
Director of Clinical Research, Institute for Research on Equity and Community Health (iREACH)
Dr. Claudine Jurkovitz is a nephrologist, director of clinical research in iREACH and the lead for the Biostatistics Epidemiology Research Design (BERD) Core with the Delaware ACCEL-Center for Translational Research (CTR) https://www.de-ctr.org/. As such, she helps Physicians, Residents, and young Investigators to develop their research projects and analytical plans and to work with the iREACH Data Analytics team.
Multimedia
Experience
Intubation Timing in COVID-19 Based on ROX Index and Association With Patient Outcomes
Background: Timing of intubation in COVID-19 is controversial. We sought to determine the association of the ROX (Respiratory rate-OXygenation) index defined as [Formula: see text] divided by [Formula: see text] divided by breathing frequency at the time of intubation with clinical outcomes.
Feasibility of a Novel COVID-19 Telehealth Care Management Program Among Individuals Receiving Treatment for Opioid Use Disorder: Analysis of a Pilot Program
The emergence of COVID-19 exacerbated the existing epidemic of opioid use disorder (OUD) across the United States due to the disruption of in-person treatment and support services. Increased use of technology including telehealth and the development of new partnerships may facilitate coordinated treatment interventions that comprehensively address the health and well-being of individuals with OUD.
Escalation of Opioid Withdrawal Frequency and Subsequent AMA Rates in Hospitalized Patients From 2017 to 2020
Objective: To measure trends for the emergence of opioid withdrawal (OW) and leaving against medical advice (AMA) among hospitalized patients. Method: Retrospective time-series of hospitalized patients with OW, defined by a Clinical Opioid Withdrawal score >=8, using electronic health record data at a tertiary health system and of patients with a discharge status of AMA from January 1, 2017 to December 31, 2020.
Development and Validation of a Pragmatic Electronic Phenotype for CKD
Background and objectives
Poor identification of individuals with CKD is a major barrier to research and appropriate clinical management of the disease. We aimed to develop and validate a pragmatic electronic (e-) phenotype to identify patients likely to have CKD.
Delaware Journal of Public Health, Chronic Disease, Part 1
Part 1 of a 2 part issue on Chronic Disease in Delaware. This issue contains articles on Asthma, Chronic Kidney Disease, Cardiovascular Disease, Arthritis, Vaccines & Chronic Disease, Diabetes, Nursing and Chronic Disease Prevention and Management, Primary Care Physician Management, Teen Perceptions of Sexual Activity, and the Cookfresh Program.
Association Between Lack of Health Insurance and Risk of Death and ESRD: Results From the Kidney Early Evaluation Program (KEEP)
Background
Uninsured adults in the United States have poor access to health care services and worse health outcomes than insured adults. Little is known about the association between lack of insurance and chronic kidney disease (CKD) progression to end-stage renal disease (ESRD) or death in patients at high risk of kidney disease. We used 2000–2011 data from the National Kidney Foundation’s Kidney Early Evaluation Program (KEEP) to examine this association.
20th ChristianaCare Way Award Ceremony
Computer Sciences Seminar
University of Delaware
Value Institute Spring Symposium
- English
- French
Claudine Jurkovitz, M.D., MPH
Director of Clinical Research, Institute for Research on Equity and Community Health (iREACH)
Contact the Media Team
For the best experience in addressing your media or interview request, please use the form below, and the first available member of our media relations team will assist you.